Cas:744984-13-2 2-(2-amino-4-methoxyphenyl)acetic acid manufacturer & supplier

Chemical Name:2-(2-amino-4-methoxyphenyl)acetic acid

CAS.NO:744984-13-2

Synonyms:2-AMINO-4-METHOXYPHENYLACETIC ACID;Benzeneacetic acid,2-amino-4-methoxy

Molecular Formula:C₉H₁₁NO₃

Molecular Weight:181.18900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:72.55000

Exact Mass:181.07400

LogP:1.48570

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-AMINO-4-METHOXYPHENYLACETIC ACID chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzeneacetic acid,2-amino-4-methoxy physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzeneacetic acid,2-amino-4-methoxy Use and application,2-AMINO-4-METHOXYPHENYLACETIC ACID technical grade,usp/ep/jp grade.

Related News: The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route. 2-(2-amino-4-methoxyphenyl)acetic acid manufacturer Javier Valero-Elizondo, M.D., M.P.H., from the Houston Methodist DeBakey Heart and Vascular Center in Texas, and colleagues compared FT for individuals with ASCVD only, cancer only, both ASCVD and cancer, and neither ASCVD nor cancer using data from the National Health Interview Survey. 2-(2-amino-4-methoxyphenyl)acetic acid supplier The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace. 2-(2-amino-4-methoxyphenyl)acetic acid vendor The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route. 2-(2-amino-4-methoxyphenyl)acetic acid factory Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.